Literature DB >> 16649218

Quality of life in long-term survivors of bladder cancer.

Veerasathpurush Allareddy1, Julianna Kennedy, Michele M West, Badrinath R Konety.   

Abstract

BACKGROUND: The quality of life (QOL) of long-term survivors of bladder cancer in a population-based registry was assessed.
METHODS: The Functional Assessment of Cancer Therapy (FACT-BL) instrument was used to evaluate QOL in a population-based sample of bladder cancer patients. QOL scores were compared between those undergoing radical cystectomy (RC) or those with an intact bladder (BI) and between continent and conduit urinary diversion groups. The influence of current age and time since diagnosis of cancer on QOL were also examined. Multivariate regression analyses were performed to examine the influence of age, time since diagnosis, current condition, treatment, stage of cancer, and comorbid conditions on QOL.
RESULTS: A total of 259 patients participated in the study who had undergone RC (n=82) or other therapy (BI) (n=177). There were no differences in general QOL scores between RC and BI groups and between the 2 urinary diversion groups, but patients undergoing RC had worse sexual function scores. QOL scores for BI patients tended to decrease with increasing age (P=.01). Presence of comorbid conditions lowered QOL (P<.05).
CONCLUSIONS: General QOL does not vary among long-term bladder cancer survivors regardless of treatment, but sexual functioning can be adversely affected in those undergoing cystectomy. Long-term QOL declines even in those with intact bladders, particularly in those with comorbidities. Copyright (c) 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 16649218     DOI: 10.1002/cncr.21896

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  37 in total

1.  Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years.

Authors:  Atsushi Takenaka; Isao Hara; Hideo Soga; Iori Sakai; Tomoaki Terakawa; Mototsugu Muramaki; Hideaki Miyake; Kazushi Tanaka; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2010-10-30       Impact factor: 2.370

2.  Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.

Authors:  Salvatore Siracusano; Carolina D'Elia; Maria Angela Cerruto; Omar Saleh; Sergio Serni; Mauro Gacci; Stefano Ciciliato; Alchiede Simonato; Antonio Porcaro; Vincenzo DE Marco; Renato Talamini; Laura Toffoli; Francesco Visalli; Mauro Niero; Cristina Lonardi; Ciro Imbimbo; Paolo Verze; Vincenzo Mirone; Marco Racioppi; Massimo Iafrate; Giovanni Cacciamani; Davide DE Marchi; Pierfrancesco Bassi; Walter Artibani
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

3.  Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer.

Authors:  S Singer; C Ziegler; T Schwalenberg; A Hinz; H Götze; T Schulte
Journal:  Support Care Cancer       Date:  2012-12-14       Impact factor: 3.603

4.  Idiographic quality of life assessment before radical cystectomy.

Authors:  Christopher B Anderson; Bruce Rapkin; Brieyona C Reaves; Arony J Sun; Bradley Morganstern; Guido Dalbagni; Machele Donat; Harry W Herr; Vincent P Laudone; Bernard H Bochner
Journal:  Psychooncology       Date:  2015-11-30       Impact factor: 3.894

Review 5.  Sexual dysfunction after cystectomy and urinary diversion.

Authors:  Rishi A Modh; John P Mulhall; Scott M Gilbert
Journal:  Nat Rev Urol       Date:  2014-07-01       Impact factor: 14.432

Review 6.  Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Arnulf Stenzl; Markus Kuczyk
Journal:  World J Urol       Date:  2011-02-05       Impact factor: 4.226

7.  Neurotrophic effects of brain-derived neurotrophic factor and vascular endothelial growth factor in major pelvic ganglia of young and aged rats.

Authors:  Guiting Lin; Alan W Shindel; Thomas M Fandel; Anthony J Bella; Ching-Shwun Lin; Tom F Lue
Journal:  BJU Int       Date:  2009-06-02       Impact factor: 5.588

Review 8.  Quality of life following incontinent cutaneous and orthotopic urinary diversions.

Authors:  Cheryl T Lee
Journal:  Curr Treat Options Oncol       Date:  2009-08

9.  Health status and quality of life among non-Hodgkin lymphoma survivors.

Authors:  Sophia K Smith; Sheryl Zimmerman; Christianna S Williams; Bradley J Zebrack
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

10.  Quality-of-life assessment after palliative interventions to manage malignant ureteral obstruction.

Authors:  Wayne Laurence Monsky; Chris Molloy; Bedro Jin; Timothy Nolan; Dayantha Fernando; Shaun Loh; Chin-Shang Li
Journal:  Cardiovasc Intervent Radiol       Date:  2013-02-13       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.